KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insulet (PODD) Operating Income (2016 - 2026)

Insulet filings provide 16 years of Operating Income readings, the most recent being $146.3 million for Q4 2025.

  • On a quarterly basis, Operating Income rose 33.85% to $146.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $473.9 million, a 53.47% increase, with the full-year FY2025 number at $473.8 million, up 53.38% from a year prior.
  • Operating Income hit $146.3 million in Q4 2025 for Insulet, up from $117.7 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $146.3 million in Q4 2025 to a low of -$26.7 million in Q2 2022.
  • Median Operating Income over the past 5 years was $52.1 million (2021), compared with a mean of $58.3 million.
  • Biggest five-year swings in Operating Income: tumbled 201.52% in 2022 and later soared 1789.66% in 2023.
  • Insulet's Operating Income stood at $49.7 million in 2021, then tumbled by 52.72% to $23.5 million in 2022, then surged by 353.19% to $106.5 million in 2023, then increased by 2.63% to $109.3 million in 2024, then skyrocketed by 33.85% to $146.3 million in 2025.
  • The last three reported values for Operating Income were $146.3 million (Q4 2025), $117.7 million (Q3 2025), and $121.1 million (Q2 2025) per Business Quant data.